Matthew Mossanen

10PUBLICATIONS
47CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biologySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 02, 2026
A Phase I trial of PLZ4-coated paclitaxel-loaded micelles in patients with refractory non-muscle-invasive bladder cancer.

|Jan 26, 2026
ctDNA Dynamics and Recurrence Patterns after Organ-Sparing Trimodality Therapy for Bladder Cancer.

Ilana B Epstein, Adetolani Odogiyon, Stephanie Berg

|Nov 21, 2023
Smoking status among cancer patients by specialty: A U.S. nationwide representative analysis.

José Ignacio Nolazco, Yuzhe Tang, Khalid Y Alkhatib

|Apr 28, 2021
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration.

Praful Ravi, Gregory R Pond, Leonidas N Diamantopoulos

|Dec 22, 2020
The impact of smoking on radical cystectomy complications increases in elderly patients.

Lorine Haeuser, Maya Marchese, Deborah Schrag

|Jan 05, 2020
Beyond bladder cancer surveillance: building a survivorship clinic.

Matthew Mossanen, Steven L Chang

Pageof 2

Frequent Collaborators

2 joint publications

Quoc-Dien Trinh

1 joint publications

Angela B Smith

1 joint publications

Jeffrey J Leow

1 joint publications

Sebastian Berg